S&P 500   4,597.43 (-1.24%)
DOW   34,666.57 (-1.34%)
QQQ   395.00 (-1.17%)
AAPL   164.27 (+2.51%)
MSFT   332.17 (-1.32%)
FB   327.78 (-3.03%)
GOOGL   2,855.15 (-1.91%)
AMZN   3,513.63 (-1.35%)
TSLA   1,136.76 (-0.02%)
NVDA   325.29 (-2.54%)
BABA   127.18 (-3.37%)
NIO   39.21 (-3.09%)
CGC   10.50 (-5.06%)
AMD   158.29 (-2.24%)
GE   95.48 (-2.97%)
MU   85.23 (-1.06%)
T   22.73 (-4.86%)
F   19.25 (-2.14%)
DIS   144.40 (-2.31%)
ACB   6.27 (-2.64%)
AMC   34.23 (-7.08%)
PFE   54.17 (+3.38%)
BA   195.95 (-1.28%)
S&P 500   4,597.43 (-1.24%)
DOW   34,666.57 (-1.34%)
QQQ   395.00 (-1.17%)
AAPL   164.27 (+2.51%)
MSFT   332.17 (-1.32%)
FB   327.78 (-3.03%)
GOOGL   2,855.15 (-1.91%)
AMZN   3,513.63 (-1.35%)
TSLA   1,136.76 (-0.02%)
NVDA   325.29 (-2.54%)
BABA   127.18 (-3.37%)
NIO   39.21 (-3.09%)
CGC   10.50 (-5.06%)
AMD   158.29 (-2.24%)
GE   95.48 (-2.97%)
MU   85.23 (-1.06%)
T   22.73 (-4.86%)
F   19.25 (-2.14%)
DIS   144.40 (-2.31%)
ACB   6.27 (-2.64%)
AMC   34.23 (-7.08%)
PFE   54.17 (+3.38%)
BA   195.95 (-1.28%)
S&P 500   4,597.43 (-1.24%)
DOW   34,666.57 (-1.34%)
QQQ   395.00 (-1.17%)
AAPL   164.27 (+2.51%)
MSFT   332.17 (-1.32%)
FB   327.78 (-3.03%)
GOOGL   2,855.15 (-1.91%)
AMZN   3,513.63 (-1.35%)
TSLA   1,136.76 (-0.02%)
NVDA   325.29 (-2.54%)
BABA   127.18 (-3.37%)
NIO   39.21 (-3.09%)
CGC   10.50 (-5.06%)
AMD   158.29 (-2.24%)
GE   95.48 (-2.97%)
MU   85.23 (-1.06%)
T   22.73 (-4.86%)
F   19.25 (-2.14%)
DIS   144.40 (-2.31%)
ACB   6.27 (-2.64%)
AMC   34.23 (-7.08%)
PFE   54.17 (+3.38%)
BA   195.95 (-1.28%)
S&P 500   4,597.43 (-1.24%)
DOW   34,666.57 (-1.34%)
QQQ   395.00 (-1.17%)
AAPL   164.27 (+2.51%)
MSFT   332.17 (-1.32%)
FB   327.78 (-3.03%)
GOOGL   2,855.15 (-1.91%)
AMZN   3,513.63 (-1.35%)
TSLA   1,136.76 (-0.02%)
NVDA   325.29 (-2.54%)
BABA   127.18 (-3.37%)
NIO   39.21 (-3.09%)
CGC   10.50 (-5.06%)
AMD   158.29 (-2.24%)
GE   95.48 (-2.97%)
MU   85.23 (-1.06%)
T   22.73 (-4.86%)
F   19.25 (-2.14%)
DIS   144.40 (-2.31%)
ACB   6.27 (-2.64%)
AMC   34.23 (-7.08%)
PFE   54.17 (+3.38%)
BA   195.95 (-1.28%)
NASDAQ:IMCC

IM Cannabis Stock Competitors

$4.31
+0.23 (+5.64%)
(As of 11/30/2021 02:03 PM ET)
Add
Compare
Today's Range
$3.84
$4.32
50-Day Range
$2.29
$4.30
52-Week Range
$2.26
$11.63
Volume
24,120 shs
Average Volume
406,715 shs
Market Capitalization
$292.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

IM Cannabis (NASDAQ:IMCC) Vs. TLRY, CGC, USNA, CRON, ACB, SNDL, HEXO, CDXC, NAII, and MDWD

Should you be buying IM Cannabis stock or one of its competitors? The main competitors of IM Cannabis include Tilray (TLRY), Canopy Growth (CGC), USANA Health Sciences (USNA), Cronos Group (CRON), Aurora Cannabis (ACB), Sundial Growers (SNDL), HEXO (HEXO), ChromaDex (CDXC), Natural Alternatives International (NAII), and MediWound (MDWD). These companies are all part of the "medicinals & botanicals" industry.These companies are all part of the "medicinals & botanicals" industry.

IM Cannabis vs.

Canopy Growth (NASDAQ:CGC) and IM Cannabis (NASDAQ:IMCC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, community ranking, analyst recommendations, risk, dividends, media sentiment and valuation.

14.2% of Canopy Growth shares are owned by institutional investors. Comparatively, 13.7% of IM Cannabis shares are owned by institutional investors. 0.1% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

IM Cannabis has a net margin of -60.79% compared to Canopy Growth's net margin of -201.25%. IM Cannabis' return on equity of -20.69% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth -201.25% -24.66% -14.91%
IM Cannabis -60.79% -20.69% -14.80%

Canopy Growth presently has a consensus price target of $24.19, suggesting a potential upside of 131.50%. IM Cannabis has a consensus price target of $8.42, suggesting a potential upside of 102.81%. Given Canopy Growth's higher possible upside, analysts clearly believe Canopy Growth is more favorable than IM Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
4 Sell rating(s)
10 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.88
IM Cannabis
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Canopy Growth had 4 more articles in the media than IM Cannabis. MarketBeat recorded 12 mentions for Canopy Growth and 8 mentions for IM Cannabis. Canopy Growth's average media sentiment score of 0.35 beat IM Cannabis' score of 0.29 indicating that Canopy Growth is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
3 Very Positive mention(s)
5 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
IM Cannabis
1 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Canopy Growth received 8 more outperform votes than IM Cannabis when rated by MarketBeat users. However, 75.00% of users gave IM Cannabis an outperform vote while only 30.43% of users gave Canopy Growth an outperform vote.

CompanyUnderperformOutperform
Canopy GrowthOutperform Votes
14
30.43%
Underperform Votes
32
69.57%
IM CannabisOutperform Votes
6
75.00%
Underperform Votes
2
25.00%

IM Cannabis has lower revenue, but higher earnings than Canopy Growth. IM Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$414.03 million9.98-$1.32 billion-$2.66-3.95
IM Cannabis$11.86 million24.65-$21.42 million-$0.62-6.95

Summary

IM Cannabis beats Canopy Growth on 9 of the 17 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IMCC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IM Cannabis (NASDAQ:IMCC) vs. Its Competitors

TypeIM CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$292.39M$900.42M$4.94B$7.86B
Dividend YieldN/A2.09%2.04%2.48%
P/E Ratio-6.955.0319.3921.34
Price / Sales24.6552.522,542.81281.32
Price / CashN/A11.0441.41137.68
Price / BookN/A4.419.5410.62
Net Income-$21.42M-$85.34M$95.31M$153.87M
7 Day Performance38.14%1.48%111.29%-3.20%
1 Month Performance56.73%-6.06%106.84%-6.44%
1 Year PerformanceN/A-4.06%161.16%29.76%

IM Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray
1.7657 of 5 stars
$9.96
+2.9%
$14.35
+44.0%
+20.6%$4.59B$513.09M-5.162,100
CGC
Canopy Growth
1.1874 of 5 stars
$10.50
+5.3%
$24.19
+130.4%
-61.9%$4.13B$414.03M-3.953,259Analyst Downgrade
USNA
USANA Health Sciences
2.3598 of 5 stars
$99.09
+0.9%
$124.00
+25.1%
+30.5%$1.93B$1.13B15.131,943Short Interest ↓
CRON
Cronos Group
1.6431 of 5 stars
$4.45
+0.2%
$8.17
+83.5%
-47.3%$1.66B$46.72M-10.85665Upcoming Earnings
ACB
Aurora Cannabis
1.6134 of 5 stars
$6.27
+2.7%
$7.08
+13.0%
-38.5%$1.24B$191.43M-2.401,761
SNDL
Sundial Growers
1.4914 of 5 stars
$0.61
+3.5%
$0.73
+19.5%
+70.7%$1.02B$45.48M-3.41394
HEXO
HEXO
1.6108 of 5 stars
$1.07
+5.2%
$5.86
+450.1%
+29.4%$331.91M$97M-1.52N/AGap Down
CDXC
ChromaDex
1.8448 of 5 stars
$4.70
+1.1%
$13.00
+176.6%
-5.2%$320.96M$59.26M-10.93110
NAII
Natural Alternatives International
1.5081 of 5 stars
$12.85
+1.9%
N/A+27.1%$81.79M$178.52M6.95175Short Interest ↑
News Coverage
MDWD
MediWound
1.7581 of 5 stars
$2.63
+1.5%
$7.50
+185.2%
-31.3%$71.64M$21.76M-6.5775Short Interest ↓
MTEX
Mannatech
1.7964 of 5 stars
$36.00
+2.6%
N/A+100.7%$69.12M$151.41M9.45226Dividend Announcement
GRVI
Grove
0 of 5 stars
$4.75
+1.9%
N/AN/A$67.50M$24.09M0.0090Short Interest ↑
BON
Bon Natural Life
0 of 5 stars
$5.35
+0.4%
N/AN/A$42.80M$18.22M0.008,787
HAPP
Happiness Biotech Group
1.3265 of 5 stars
$0.68
+4.7%
N/A-63.7%$21.73M$71.49M0.00151
This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.